Nalbuphine and Buprenorphine: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Buprenorphine
Nalbuphine
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Both buprenorphine and nalbuphine act on the same opioid receptors, but in a tug-of-war way. Nalbuphine partly blocks those receptors, so if you take it while on buprenorphine, it can push the buprenorphine off and actually make your pain control weaker. It can even trigger sudden withdrawal feelings like sweating, chills, nausea, and body aches.
On top of that, both are opioids, so together they can slow your breathing and make you very sleepy. This is why the two are usually not used together. The good news: your care team can plan around this and keep you safe. Please talk with your pharmacist or doctor before combining them.
Direction: Nalbuphine, a mixed opioid agonist/antagonist, can displace the partial agonist buprenorphine at mu-opioid receptors, reducing analgesia and potentially precipitating withdrawal. Concurrently, additive CNS/respiratory depression and additive serotonergic effects raise risk of respiratory depression, profound sedation, and serotonin syndrome.
- Mechanism: competitive opioid receptor antagonism plus additive CNS depression/serotonergic effects (PD interaction; neither is a relevant prodrug here).
- Evidence: theoretical; onset unspecified.
- Severity: major.
- Management: avoid combination; if unavoidable, monitor for sedation, respiratory depression, and serotonin syndrome, use lowest effective doses, and strongly consider prescribing naloxone.
What happens
Reduced analgesic effect or precipitation of withdrawal symptoms, and an increased risk of serotonin syndrome and respiratory depression
Interaction Deep Dive
Do not use buprenorphine together with a mixed opioid agonist/antagonist or a partial agonist opioid analgesic, because doing so can diminish the analgesic effect of buprenorphine and may trigger withdrawal symptoms. Furthermore, giving buprenorphine alongside a CNS depressant can cause additive CNS depression, raising the likelihood of serotonin syndrome and respiratory depression, profound sedation, coma, and death. Stopping the other CNS depressants is preferred rather than using them together. For certain patients, it may be appropriate to monitor them at a higher level of care or to taper. For others, slowly tapering a patient off a prescribed benzodiazepine or another CNS depressant, or lowering it to the smallest effective dose, may be suitable. When combined use cannot be avoided, watch for sedation, respiratory depression, and any signs and symptoms of serotonin syndrome; consider alternative approaches for managing anxiety or insomnia, and strongly consider prescribing naloxone for the emergency treatment of opioid overdose1.
Why it happens (mechanism)
Opioid receptor antagonism; additive serotonergic effects and respiratory depression
How to manage this interaction
The safest approach is usually to avoid using these two together, because nalbuphine can blunt buprenorphine's pain relief and set off withdrawal, and the combination adds to breathing and sedation risks.
- Keep taking your medications exactly as prescribed and do not stop or change anything on your own.
- Tell any provider or ER that you take buprenorphine before nalbuphine is given.
- Your care team may choose an alternative pain option, or watch you more closely for heavy sedation, slowed breathing, or withdrawal symptoms.
- Ask your pharmacist or doctor whether having naloxone on hand is right for you.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Nalbuphine and Buprenorphine together?
Buprenorphine and nalbuphine generally should not be combined, since nalbuphine can weaken buprenorphine's effect, trigger withdrawal, and add to sedation and breathing risks. Talk with your pharmacist or doctor before using both. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Nalbuphine and Buprenorphine interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Nalbuphine and Buprenorphine interaction managed?
The safest approach is usually to avoid using these two together, because nalbuphine can blunt buprenorphine's pain relief and set off withdrawal, and the combination adds to breathing and sedation risks. Keep taking your medications exactly as prescribed and do not stop or change anything on your own. Tell any provider or ER that you take buprenorphine before nalbuphine is given. Your care team m… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Nalbuphine or Buprenorphine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: SUBUTEX(R) sublingual tablets, buprenorphine sublingual tablets. Indivior Inc (per FDA), North Chesterfield, VA, 2021. DailyMed
Keep reading about Buprenorphine
Keep reading about Nalbuphine
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist